Femasys (FEMY) Total Current Liabilities (2020 - 2026)
Femasys (FEMY) posted Total Current Liabilities of $3.2 million for Q1 2026, down 13.23% on a QoQ basis from $3.6 million in Q4 2025, and down 67.94% year-over-year from $9.8 million in Q1 2025.
Femasys (FEMY) Total Current Liabilities (2020 - 2026) Analysis & Trends
Femasys' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- Quarterly Total Current Liabilities fell 67.94% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 67.94% YoY) and the FY2025 annual result came in at $3.6 million, down 57.63% from the prior year.
- Total Current Liabilities was $3.2 million for Q1 2026 at Femasys, down from $3.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $11.0 million in Q2 2025 and bottomed at $1.4 million in Q2 2023.
- A 5-year average of $4.1 million and a median of $2.5 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2025 — Total Current Liabilities surged 344.95% — and 2026, when it tumbled 67.94%.
- Femasys' Total Current Liabilities stood at $1.5 million in 2022, then soared by 99.9% to $3.1 million in 2023, then surged by 181.03% to $8.6 million in 2024, then plunged by 57.63% to $3.6 million in 2025, then retreated by 13.23% to $3.2 million in 2026.
- Business Quant data shows FEMY's Total Current Liabilities at $3.2 million in Q1 2026, $3.6 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 3.64 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 10.96 Mn |
| Mar 31, 2025 | 9.84 Mn |
| Dec 31, 2024 | 8.58 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 3.05 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 1.82 Mn |
| Jun 30, 2021 | 2.32 Mn |